Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 53

1.

Immune regulation of metastasis: mechanistic insights and therapeutic opportunities.

Blomberg OS, Spagnuolo L, de Visser KE.

Dis Model Mech. 2018 Oct 24;11(10). pii: dmm036236. doi: 10.1242/dmm.036236. Review.

2.

Cancer-Cell-Intrinsic Mechanisms Shaping the Tumor Immune Landscape.

Wellenstein MD, de Visser KE.

Immunity. 2018 Mar 20;48(3):399-416. doi: 10.1016/j.immuni.2018.03.004. Review.

PMID:
29562192
3.

The adaptive immune system promotes initiation of prostate carcinogenesis in a human c-Myc transgenic mouse model.

Melis MHM, Nevedomskaya E, van Burgsteden J, Cioni B, van Zeeburg HJT, Song JY, Zevenhoven J, Hawinkels LJAC, de Visser KE, Bergman AM.

Oncotarget. 2017 Sep 28;8(55):93867-93877. doi: 10.18632/oncotarget.21305. eCollection 2017 Nov 7.

4.

Neutrophils take a round-trip.

Garner H, de Visser KE.

Science. 2017 Oct 6;358(6359):42-43. doi: 10.1126/science.aap8361. No abstract available.

PMID:
28983037
5.

Mammary tumor-derived CCL2 enhances pro-metastatic systemic inflammation through upregulation of IL1β in tumor-associated macrophages.

Kersten K, Coffelt SB, Hoogstraat M, Verstegen NJM, Vrijland K, Ciampricotti M, Doornebal CW, Hau CS, Wellenstein MD, Salvagno C, Doshi P, Lips EH, Wessels LFA, de Visser KE.

Oncoimmunology. 2017 Jun 19;6(8):e1334744. doi: 10.1080/2162402X.2017.1334744. eCollection 2017.

6.

Genetically engineered mouse models in oncology research and cancer medicine.

Kersten K, de Visser KE, van Miltenburg MH, Jonkers J.

EMBO Mol Med. 2017 Feb;9(2):137-153. doi: 10.15252/emmm.201606857. Review.

7.
8.

Neutrophils in cancer: neutral no more.

Coffelt SB, Wellenstein MD, de Visser KE.

Nat Rev Cancer. 2016 Jul;16(7):431-46. doi: 10.1038/nrc.2016.52. Epub 2016 Jun 10. Review.

PMID:
27282249
9.

CANCER. How neutrophils promote metastasis.

Tüting T, de Visser KE.

Science. 2016 Apr 8;352(6282):145-6. doi: 10.1126/science.aaf7300. No abstract available.

PMID:
27124439
10.

Revving Up Dendritic Cells while Braking PD-L1 to Jump-Start the Cancer-Immunity Cycle Motor.

Coffelt SB, de Visser KE.

Immunity. 2016 Apr 19;44(4):722-4. doi: 10.1016/j.immuni.2016.03.014.

11.

Systemic inflammation: Cancer's long-distance reach to maximize metastasis.

Coffelt SB, de Visser KE.

Oncoimmunology. 2015 Aug 17;5(2):e1075694. eCollection 2016 Feb.

12.

Exploiting the Immunomodulatory Properties of Chemotherapeutic Drugs to Improve the Success of Cancer Immunotherapy.

Kersten K, Salvagno C, de Visser KE.

Front Immunol. 2015 Oct 7;6:516. doi: 10.3389/fimmu.2015.00516. eCollection 2015. Review.

13.

Immune-mediated mechanisms influencing the efficacy of anticancer therapies.

Coffelt SB, de Visser KE.

Trends Immunol. 2015 Apr;36(4):198-216. doi: 10.1016/j.it.2015.02.006. Review.

PMID:
25857662
14.

IL-17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis.

Coffelt SB, Kersten K, Doornebal CW, Weiden J, Vrijland K, Hau CS, Verstegen NJM, Ciampricotti M, Hawinkels LJAC, Jonkers J, de Visser KE.

Nature. 2015 Jun 18;522(7556):345-348. doi: 10.1038/nature14282. Epub 2015 Mar 30.

15.

Morphine does not facilitate breast cancer progression in two preclinical mouse models for human invasive lobular and HER2⁺ breast cancer.

Doornebal CW, Vrijland K, Hau CS, Coffelt SB, Ciampricotti M, Jonkers J, de Visser KE, Hollmann MW.

Pain. 2015 Aug;156(8):1424-32. doi: 10.1097/j.pain.0000000000000136.

PMID:
25734987
16.

Targeting tumor-associated macrophages with anti-CSF-1R antibody reveals a strategy for cancer therapy.

Ries CH, Cannarile MA, Hoves S, Benz J, Wartha K, Runza V, Rey-Giraud F, Pradel LP, Feuerhake F, Klaman I, Jones T, Jucknischke U, Scheiblich S, Kaluza K, Gorr IH, Walz A, Abiraj K, Cassier PA, Sica A, Gomez-Roca C, de Visser KE, Italiano A, Le Tourneau C, Delord JP, Levitsky H, Blay JY, Rüttinger D.

Cancer Cell. 2014 Jun 16;25(6):846-59. doi: 10.1016/j.ccr.2014.05.016. Epub 2014 Jun 2.

17.

Cancer: Inflammation lights the way to metastasis.

Coffelt SB, de Visser KE.

Nature. 2014 Mar 6;507(7490):48-9. doi: 10.1038/nature13062. Epub 2014 Feb 26. No abstract available.

PMID:
24572360
18.

A preclinical mouse model of invasive lobular breast cancer metastasis.

Doornebal CW, Klarenbeek S, Braumuller TM, Klijn CN, Ciampricotti M, Hau CS, Hollmann MW, Jonkers J, de Visser KE.

Cancer Res. 2013 Jan 1;73(1):353-63. doi: 10.1158/0008-5472.CAN-11-4208. Epub 2012 Nov 14.

19.

Developmental stage-specific contribution of LGR5(+) cells to basal and luminal epithelial lineages in the postnatal mammary gland.

de Visser KE, Ciampricotti M, Michalak EM, Tan DW, Speksnijder EN, Hau CS, Clevers H, Barker N, Jonkers J.

J Pathol. 2012 Nov;228(3):300-9. doi: 10.1002/path.4096.

PMID:
22926799
20.

Chemotherapy response of spontaneous mammary tumors is independent of the adaptive immune system.

Ciampricotti M, Hau CS, Doornebal CW, Jonkers J, de Visser KE.

Nat Med. 2012 Mar 6;18(3):344-6; author reply 346. doi: 10.1038/nm.2652. No abstract available.

PMID:
22395693

Supplemental Content

Loading ...
Support Center